Unusual vasovagal-type autonomic dysfunction secondary to immune checkpoint inhibitor therapy

被引：0

作者：

Danley, Kelsey ^{[1
]}

Fidler, Mary Jo ^{[2
]}

Sadaf, Aliyah ^{[1
]}

Okwuosa, Tochukwu M. ^{[3
]}

机构：

[1] Rush Univ, Med Ctr, Internal Med, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Oncol, Chicago, IL USA

[3] Rush Univ, Med Ctr, Dept Internal Med, Div Cardiol, Chicago, IL USA

来源：

BMJ CASE REPORTS | 2023年 / 16卷 / 02期

关键词：

Cancer; see Oncology; Cancer intervention; Cardiovascular system; ADVERSE EVENTS;

D O I：

10.1136/bcr-2022-251034

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present the case of a patient with oral squamous cell carcinoma treated with the programmed death ligand inhibitor, pembrolizumab, an immune checkpoint inhibitor. She subsequently developed vasovagal-type autonomic dysfunction thought to be secondary to the pembrolizumab. The patient's vasovagal symptoms resolved with the initiation of oral glucocorticoids.

引用

页数：3

共 50 条

[41] Therapy: Rheumatic disease after immune checkpoint inhibitor therapy
Ummarino D.
Nature Reviews Rheumatology, 2017, 13 (8) : 450 - 450
[42] Morphology of immune-mediated hepatitis: A comparison between immune checkpoint inhibitor therapy and combined immune checkpoint inhibitor/anti-angiogenic therapy
Zhang, Qiongyan
Chen, Lingli
Guo, Xinxin
Shen, Licheng
Huang, Yufeng
Chen, Yi
Zhang, Ningping
Ge, Ningling
Gao, Hong
Zhang, Wen
Hou, Yingyong
Ji, Yuan
ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 68
[43] Cardiogenic shock secondary to immune checkpoint inhibitor associated myocarditis
Lee, Kuan Ken
Bain, Tanith
Flapan, Andrew
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2024, 54 (03): : 225 - 230
[44] Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy
Chin, Collin K.
Hall, Sara
Green, Celia
Van Hazel, Guy
Spagnolo, Dominic
Cheah, Chan Yoon
EUROPEAN JOURNAL OF CANCER, 2019, 115 : 84 - 87
[45] IgLON5 autoimmunity secondary to immune checkpoint inhibitor
Itoh, Christopher
Swart, Grace
Louis, Erik St.
Gandhi, Manish
Dubey, Divyanshu
JOURNAL OF NEUROIMMUNOLOGY, 2025, 399
[46] Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
Fletcher, James
Bird, Robert
Mclean, Andrew J. W.
O'Byrne, Kenneth
Xu, Wen
JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (11):
[47] Sclerosing mesenteritis following immune checkpoint inhibitor therapy
Kuang, Andrew G. G.
Sperling, Gabriel
Liang, Tom Z. Z.
Lu, Yang
Tan, Dongfeng
Bollin, Kathryn
Johnson, Douglas B. B.
Manzano, Joanna-Grace M.
Shatila, Malek
Thomas, Anusha S. S.
Thompson, John A. A.
Zhang, Hao Chi
Wang, Yinghong
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 9221 - 9227
[48] Arthritis risk with immune checkpoint inhibitor therapy for cancer
Pundole, Xerxes
Abdel-Wahab, Noha
Suarez-Almazor, Maria E.
CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 293 - 299
[49] A rare cutaneous manifestation of immune checkpoint inhibitor therapy
Cherneskie Jr, John
Tuan, Alyssa
Corey, Zachary
Polimera, Hyma
CLINICAL CASE REPORTS, 2023, 11 (04):
[50] Risks for Venous Thromboembolism with Immune Checkpoint Inhibitor Therapy
Connors, Jean M.
Sussman, Tamara A.
Dryg, Ian D.
Giobbe-Hurder, Anita
Manos, Michael P.
Weirather, Jason L.
Hodi, Stephen
BLOOD, 2023, 142

← 1 2 3 4 5 →